Buhai J. Wang
Yanghzou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial.
Journal: Clinical lung cancer
Published: March 20, 2026
A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC).
Journal: Future oncology (London, England)
Published: December 04, 2024
Sintilimab plus HPV vaccine for recurrent or metastatic cervical cancer.
Journal: Journal for immunotherapy of cancer
Published: November 05, 2024
Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 16, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: August 25, 2024
Research trends of neoadjuvant therapy in lung cancer: a bibliometric analysis.
Journal: Discover oncology
Published: August 22, 2024
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study.
Journal: EClinicalMedicine
Published: January 10, 2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.
Journal: Cancer cell
Published: January 03, 2024
LncRNA LINC00342 regulates gastric cancer cell proliferation, migration and invasion by targeting miR-596
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: November 07, 2023
Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 24, 2023
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis.
Journal: JTO clinical and research reports
Published: June 02, 2023
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
Journal: British journal of cancer
Published: March 13, 2023
Last Updated: 09/26/2026